Liverpool scientists awarded funding boost for dementia research
21 September 2017
A research team at the University of Liverpool has been awarded £50,000 to develop pioneering technology that could improve our understanding of Alzheimer’s disease.
The study, funded by the charity Alzheimer’s Research UK, comes on World Alzheimer’s Day (Thursday 21 September), an initiative to raise global awareness of Alzheimer’s disease and other dementias as well as highlighting the progress that research is making toward tackling them.
Dementia is the leading cause of death in England and Wales, and a condition that affects around 93,000 people in the North West alone. The most common cause of dementia is Alzheimer’s disease, which can lead to devastating symptoms such as memory loss, personality changes and communication problems. Symptoms get progressively worse over time until a person is unable to take care of themselves. While there is currently no treatment that can slow or stop the underlying brain changes that cause diseases like Alzheimer’s, researchers are making advances in our understanding of the disease and how to treat it.
To develop a treatment that could stop or slow the progression of Alzheimer’s, researchers must better understand what is happening to the brains of people with the disease. A protein called amyloid is thought to play a key role in the disease and begins to build up in the brain long before symptoms start to show. Finding out more about amyloid including what causes it to spread through the brain, is crucial in the hunt for ways to help people living with the disease.
Dr Jillian Madine from the University of Liverpool aims to develop an innovative new imaging method that can track the progression of amyloid over time. She hopes this will provide a clearer picture of the biological mechanisms that underpin Alzheimer’s and highlight new targets for prospective treatments.
Dr Jillian Madine said:
“Amyloid has been at the centre of Alzheimer’s research for several decades now, but there are still many unanswered questions about how this protein contributes to damage in the disease. We will use this new funding to pioneer a method of tracking amyloid protein as it begins to build up in the brain and spread between different brain regions. We are extremely grateful to Alzheimer’s Research UK for this support, and we hope to shed new light on a key process in the development of the disease.”
Dr Rosa Sancho, Head of Research at Alzheimer’s Research UK said:
“With 850,000 people in the UK living with dementia, and that number set to rise, it is essential that we work to develop new ways to tackle the condition. Innovative research techniques are helping to accelerate the pace of scientific discovery and are vital for taking on diseases like Alzheimer’s. Our research funding is driven almost entirely by public donations, so we’re incredibly grateful to our supporters for helping us to fund important studies like this one in Liverpool, which are bringing fresh ideas to the field of dementia research.”